<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2299">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01572298</url>
  </required_header>
  <id_info>
    <org_study_id>HSC20120108H</org_study_id>
    <nct_id>NCT01572298</nct_id>
  </id_info>
  <brief_title>A Prospective Study: Alveolar Ridge Augmentation Using Tenting Screws, Acellular Dermal Matrix and Combination Particulate Grafts</brief_title>
  <official_title>A Prospective Study: Alveolar Ridge Augmentation Using Tenting Screws, Acellular Dermal Matrix and Combination Particulate Grafts.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center at San Antonio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center at San Antonio</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      When a tooth or teeth are extracted, a defect in the bony ridge often forms. This loss of
      bone may make it impossible to place a dental implant. Guided bone regeneration procedures
      are used to re-establish a bone dimension sufficient to place a dental implant. The primary
      objective of the study is to determine whether there is any difference in the gain of
      horizontal alveolar ridge width following guided bone regeneration surgery using a combined
      autogenous/allogenic particulate bone graft versus a particulate allograft alone. Autogenous
      bone has historically been considered the gold standard for alveolar ridge grafting;
      however, other materials including allografts and xenografts have also been used with
      excellent results. This study evaluates the potential benefits, or lack thereof, for using a
      combined autogenous/allograft approach versus an allograft alone. The investigators will
      clinically evaluate the efficacy of this technique and determine the difference in bone
      formation between groups following healing at 5 months by observing bone growth relative to
      heads of the tenting screws placed horizontally in the locations of greatest defect in the
      alveolar ridge. A biopsy of the healed site will be taken at the time of implant placement.
      The null hypothesis is that there will be no difference in the amount of horizontal ridge
      width gain at 5 months post-grafting between the two different grafting materials (allograft
      alone versus allograft combined with autogenous bone). Furthermore, the null hypothesis is
      that histologically, the combination graft (MinerOss®/particulate autograft) will have a
      similar percentage of vital bone present at 5 months compared to the allograft-alone group
      (MinerOss®).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Gain in Horizontal Ridge Dimension</measure>
    <time_frame>5 months after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of New Bone Formation (Histologic)</measure>
    <time_frame>5 months after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Dental Alveolus</condition>
  <condition>Oral Surgical Procedures, Preprosthetic</condition>
  <arm_group>
    <arm_group_label>allograft alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>guided bone regeneration with allograft alone (includes tenting screws and overlying allograft membrane material)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>allograft combined with autograft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>guided bone regeneration with allograft and autograft combined (includes tenting screws and overlying allograft membrane material)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>allograft alone (MinerOss allograft plus Alloderm GBR membrane)</intervention_name>
    <description>use of MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
    <arm_group_label>allograft alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>allograft combined wtih autograft (combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane)</intervention_name>
    <description>use of a combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
    <arm_group_label>allograft combined with autograft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subject with a partially edentulous ridge of the maxilla or mandible with at least
             one tooth-span in length and inadequate buccolingual dimension for dental implant
             placement as measured clinically and radiographically

          -  live within &quot;catchment area&quot; of 50 mile radius from San Antonio

        Exclusion Criteria:

          -  unstable systemic disease (such as compromised immune system)

          -  patient taking steroids or other medications affecting bone metabolism

          -  patient with history of radiation therapy to head &amp; neck

          -  history of previous ridge augmentation procedure or pathology at local jaw site

          -  smokers who smoke &gt; 10 cigarettes per day
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian L Mealey, DDS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ of Texas Health Science Center at San Antonio</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of texas Health Science Center Dental School at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-3900</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <lastchanged_date>October 1, 2015</lastchanged_date>
  <firstreceived_date>April 3, 2012</firstreceived_date>
  <firstreceived_results_date>October 1, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Allograft Alone</title>
          <description>guided bone regeneration with allograft alone (includes tenting screws and overlying allograft membrane material)
allograft alone (MinerOss allograft plus Alloderm GBR membrane): use of MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
        </group>
        <group group_id="P2">
          <title>Allograft Combined With Autograft</title>
          <description>guided bone regeneration with allograft and autograft combined (includes tenting screws and overlying allograft membrane material)
allograft combined wtih autograft (combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane): use of a combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Allograft Alone</title>
          <description>guided bone regeneration with allograft alone (includes tenting screws and overlying allograft membrane material)
allograft alone (MinerOss allograft plus Alloderm GBR membrane): use of MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
        </group>
        <group group_id="B2">
          <title>Allograft Combined With Autograft</title>
          <description>guided bone regeneration with allograft and autograft combined (includes tenting screws and overlying allograft membrane material)
allograft combined wtih autograft (combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane): use of a combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="13"/>
                <measurement group_id="B3" value="27"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="49.5" spread="11.8"/>
                <measurement group_id="B2" value="47.5" spread="14.5"/>
                <measurement group_id="B3" value="48.9" spread="12.6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="12"/>
                <measurement group_id="B2" value="11"/>
                <measurement group_id="B3" value="23"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="12"/>
                <measurement group_id="B2" value="11"/>
                <measurement group_id="B3" value="23"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Gain in Horizontal Ridge Dimension</title>
        <time_frame>5 months after surgery</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Allograft Alone</title>
            <description>guided bone regeneration with allograft alone (includes tenting screws and overlying allograft membrane material)
allograft alone (MinerOss allograft plus Alloderm GBR membrane): use of MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
          </group>
          <group group_id="O2">
            <title>Allograft Combined With Autograft</title>
            <description>guided bone regeneration with allograft and autograft combined (includes tenting screws and overlying allograft membrane material)
allograft combined wtih autograft (combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane): use of a combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="12"/>
                  <measurement group_id="O2" value="11"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Gain in Horizontal Ridge Dimension</title>
            <units>gain in ridge width (mm)</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3.33" spread="0.83"/>
                  <measurement group_id="O2" value="3.09" spread="0.63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of New Bone Formation (Histologic)</title>
        <time_frame>5 months after surgery</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Allograft Alone</title>
          <description>guided bone regeneration with allograft alone (includes tenting screws and overlying allograft membrane material)
allograft alone (MinerOss allograft plus Alloderm GBR membrane): use of MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
        </group>
        <group group_id="E2">
          <title>Allograft Combined With Autograft</title>
          <description>guided bone regeneration with allograft and autograft combined (includes tenting screws and overlying allograft membrane material)
allograft combined wtih autograft (combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane): use of a combined autogenous graft and MinerOss allograft plus Alloderm GBR membrane and tenting screws</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Brian Mealey</name_or_title>
      <organization>UTHSCSA Periodontics</organization>
      <phone>210-567-3589</phone>
      <email>mealey@uthscsa.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
